OVERVIEW

• HCV Global Situation Analysis

• Pharco Pharmaceuticals, (Access, R&D and

Challenges )

• What can we do to improve accessibility

worldwide ?

• Shortening HCV treatment to < 4 weeks

(Professor Raymond F Schinazi)

• Actions speak louder than words (Key Messages)

17

19

23

28

Shortening HCV treatment to < 4 weeks Raymond F Schinazi, PhD, DSc Francis Winship Walters Professor of Pediatrics and Chemistry

Emory University , Atlanta, GA, US

Place image here

Short Duration DAA Therapy for

Hepatitis C: How Short Can We Go?

Shyam Kottilil MD, Ph.D.

Institute of Human Virology, University of Maryland, Baltimore, MD

HEPDART

Kona, HI

December 4, 2017

Short Duration HCV Therapy

Emmanuel B…..Kottilil S. Lau G. (2017) Lancet G&H

48

Key Messages

1) Egypt succeeded in transferring its position from the highest prevalence of infection with Hepatitis C worldwide, to the first country to treat all waiting list (No Patient left Behind).

2) Under the umbrella of WHO, partnership between DNDi, MPP, and Governments of low and medium income countries to find solutions for cancer and NCDs. (Together We Can).

3) Together we can eliminate Hepatitis C from low and

medium income countries, saving hundreds of thousands

of lives annually, (Stop The Wait).

52